Literature DB >> 9001226

Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.

J E Hundley1, S K Koester, D A Troyer, S G Hilsenbeck, M A Subler, J J Windle.   

Abstract

We have used an in vivo tumor model to evaluate the consequences of p53 tumor suppressor protein deficiency in a tissue-specific context. By breeding MMTV-ras transgenic mice, which are highly susceptible to the development of mammary and salivary tumors, with p53(-/-) mice, we generated three classes of animals which contained the MMTV-ras transgene but differed in their p53 functional status (ras/p53(+/+), ras/p53(+/-), or ras/p53(-/-)). ras/p53(-/-) mice developed tumors more rapidly than animals of the other two genotypes; however, the distribution of tumors was unexpectedly altered. Whereas the most frequently observed tumors in ras/p53(+/+) and ras/p53(+/-) mice were of mammary origin, ras/p53(-/-) mice developed primarily salivary tumors. In addition, the mammary and salivary tumors from ras/p53(-/-) mice consistently exhibited a number of unfavorable characteristics, including higher histologic grades, increased growth rates, and extensive genomic instability and heterogeneity, relative to tumors from ras/p53(+/+) mice. Interestingly, the increased growth rates of ras/p53(-/-) tumors appear to be due to impaired cell cycle regulation rather than decreased apoptosis, suggesting that p53-mediated tumor suppression can occur independent of its role in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9001226      PMCID: PMC231798          DOI: 10.1128/MCB.17.2.723

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

Authors:  L Rao; M Debbas; P Sabbatini; D Hockenbery; S Korsmeyer; E White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

4.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

Authors:  J Martinez; I Georgoff; J Martinez; A J Levine
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

5.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  Frequent association of p53 gene mutation in invasive bladder cancer.

Authors:  K Fujimoto; Y Yamada; E Okajima; T Kakizoe; H Sasaki; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

10.  Nuclear p53 immunoreaction associated with poor prognosis of breast cancer.

Authors:  K Iwaya; H Tsuda; H Hiraide; K Tamaki; S Tamakuma; T Fukutomi; K Mukai; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1991-07
View more
  28 in total

1.  Mouse tumor model for neurofibromatosis type 1.

Authors:  K S Vogel; L J Klesse; S Velasco-Miguel; K Meyers; E J Rushing; L F Parada
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  p21 delays tumor onset by preservation of chromosomal stability.

Authors:  Juan A Barboza; Geng Liu; Zhenlin Ju; Adel K El-Naggar; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

3.  p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.

Authors:  K C Lee; A J Crowe; M C Barton
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.

Authors:  T G Paulson; A Almasan; L L Brody; G M Wahl
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 5.  Genome Stability Requires p53.

Authors:  Christine M Eischen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

6.  The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2.

Authors:  X Zeng; F Y Shaikh; M K Harrison; A M Adon; A J Trimboli; K A Carroll; N Sharma; C Timmers; L A Chodosh; G Leone; H I Saavedra
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

7.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Loss of cryptochrome reduces cancer risk in p53 mutant mice.

Authors:  Nuri Ozturk; Jin Hyup Lee; Shobhan Gaddameedhi; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

9.  Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis.

Authors:  Benny Abraham Kaipparettu; Klaudia M Dobrzycka; Ora Britton; Adrian V Lee; Alan J Herron; Yi Li; Michael T Lewis; Daniel Medina; Steffi Oesterreich
Journal:  Mol Cancer       Date:  2009-03-06       Impact factor: 27.401

10.  Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.

Authors:  E L Milliken; K L Lozada; E Johnson; M D Landis; D D Seachrist; I Whitten; A L M Sutton; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.